Replimune
Price & Volume
Stats
See more52W Range | $1.50-$13.24 |
Market Cap | $930.5M |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.44 |
News
See moreYahoo Finance • 5 days ago
Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks
Yahoo Finance • 28 days ago
Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
Yahoo Finance • 29 days ago
Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
Yahoo Finance • last month
REPL Investors Have Opportunity to Join Replimune Group, Inc. Fraud Investigation with the Schall Law Firm
About
CEO | Dr. Sushil Patel Ph.D. |
Address | 500 Unicorn Park Drive, Woburn, MA, United States, 01801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 479 |